Quantbot Technologies’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Quantbot Technologies’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14	Closed	-$1.78K	–	1975
2022 Q4	$1.78K	Hold	14	–	–	﹤0.01%	1583
2022 Q3	$3K	Sell	14 -12	-46%	-$4.57K	﹤0.01%	1503
2022 Q2	$11K	Sell	26 -28	-52%	-$19.8K	﹤0.01%	1520
2022 Q1	$66K	Buy	54 +53	+5,300%	+$72.1K	0.01%	1139
2021 Q4	$1K	Sell	1 -1	-50%	-$6.1K	﹤0.01%	1430
2021 Q3	$45K	Buy	2 +1	+100%	+$15.9K	﹤0.01%	1126
2021 Q2	$10K	Hold	1	–	–	﹤0.01%	1308
2021 Q1	$7K	Hold	1	–	–	﹤0.01%	1277
2020 Q4	$5K	Hold	1	–	–	﹤0.01%	1161
2020 Q3	$10K	Buy	+1	New	+$9.1K	﹤0.01%	1117

Other funds holding IRLA

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantbot Technologies's IRLA Position: Q1 2023 in Review

Quantbot Technologies sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q1 2023, closing a stake of 14 shares — an estimated $1.78K sold.

Quantbot Technologies first reported a position in IRLA in Q3 2020 and held it in 10 quarters. The position peaked at $66K in Q1 2022. 42 funds tracked by Wall St. Rank hold IRLA as of Q1 2023.

Quantbot Technologies reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Quantbot Technologies sold 14 IRulya Therapeutics Inc. Common Stock shares in Q1 2023, an estimated $1.78K.
Quantbot Technologies first reported a position in IRulya Therapeutics Inc. Common Stock in Q3 2020 and held it in 10 quarters.
Quantbot Technologies's IRulya Therapeutics Inc. Common Stock position peaked at $66K in Q1 2022.
42 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.